Start Date

5-15-2025 9:30 AM

End Date

5-15-2025 11:30 AM

Description

Intro

  • Urothelial carcinoma (UC) predominately affects older adults who often face increased adverse outcomes and reduced survival.
  • Standard of care treatment entails neoadjuvant cisplatin- based chemotherapy followed by cystectomy with urinary diversion.
  • The American Society of Clinical Oncology recommends older patients with cancer undergo Comprehensive Geriatric Assessment (CGA) prior to cancer treatment.
  • The G8, a geriatric assessment tool, is a validated screening tool for identifying frailty requiring CG

Keywords

urothelial carcinoma, neoadjuvant, geriatric patients

Comments

Presented at the 2025 Jefferson Health Equity and Quality Improvement (HEQI) Summit.

Share

COinS
 
May 15th, 9:30 AM May 15th, 11:30 AM

Association of the G8 Screening Tool with Neoadjuvant Chemotherapy Outcomes in Older Adults with Urothelial Carcinoma

Intro

  • Urothelial carcinoma (UC) predominately affects older adults who often face increased adverse outcomes and reduced survival.
  • Standard of care treatment entails neoadjuvant cisplatin- based chemotherapy followed by cystectomy with urinary diversion.
  • The American Society of Clinical Oncology recommends older patients with cancer undergo Comprehensive Geriatric Assessment (CGA) prior to cancer treatment.
  • The G8, a geriatric assessment tool, is a validated screening tool for identifying frailty requiring CG